Antimicrobials 2019
 


Antimicrobials 2019 Sponsors


Antimicrobials 2019 would like to thank the following sponsors for their support:


Gold Sponsor

MSD


For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

Silver Sponsor

Cepheid


Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid and actionable test results are needed most, in fields such as critical and health-care associated infections, sexual health, genetic diseases and cancer.

Silver Sponsor

Thermo Fisher
 
Thermo Fisher Scientific is the world leader in servicing science, enabling customers to make the world healthier, cleaner and safer. Our comprehensive range includes high-end analytical and process instrumentation, laboratory equipment, a complete range of consumables, chemical and reagents as well as the service and support to optimise your results. We've combined sales and service teams to make it easier for customers to connect with all our capabilities and leading global brands. Our local team of more than 1000 employees are working together across Australia and New Zealand to provide unparalleled industry, product and application expertise. From research to academia; diagnostics, medical and healthcare; biotechnology and pharmaceutical; food, dairy and beverage; manufacturing and utilities; heavy industry, minerals, mining and petrochemical; environmental gas, water and assessment technologies.
 

Bronze Sponsor

bioMérieux


As a world leader in the field of in vitro diagnostics, bioMerieux continues its commitment to improving healthcare worldwide through a complete range of in-vitro diagnostic solutions for managing Infectious and Cardiovascular diseases. Biofire has strengthened our leadership position in molecular diagnostics and syndromic testing and we continue to innovate and design the diagnostics of the future, whilst improving laboratory efficiency and turnaround time for the benefit of the patient. Our partnership with COPAN and the distribution of the WASP and WASPLab enhances this commitment further. 

The Merieux family's commitment to serving human and animal health worldwide, has always been handled within the single concept of "One Health". In the field of antimicrobial resistance, such a holistic approach is especially important, and bioMerieux's product and service offer includes the characterisation of microbial flora, detection of specific pathogens, antibiotic resistance profiling, as well as analysis of food, drug, water and air samples in the clinical, veterinary and food sector. bioMerieux is also a long-standing international advocate for awareness-raising activities related to antibiotic resistance. It has produced a wide array of educational material, increased its sponsorship for scientific studies and organisations, and continues to communicate actively about the global antibiotic resistance threat.
 

Bronze Sponsor

BD
 
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and delivery of care. In diagnostics, BD supplies instrumentation and consumables for Microbiology, Molecular and Cytology testing, and is a leading provider of products for the safe collection and transport of diagnostic specimens. Major BD Diagnostics brands include BD KiestraTM, BD BACTECTM, BD BACTEC MGITTM, BD PhoenixTM, BD ViperTM, BD MAXTM, BD SurePathTM and BD Vacutainer®. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C.R. Bard and its products into the BD family. For more information on BD, please visit http://bd.com
 

Bronze Sponsor

Abbott

Abbott is a global leader in rapid diagnostic tests that deliver the right care, at the right time. Our comprehensive portfolio of tests provide fast, reliable and actionable information that help improve quality of care and enable better clinical and economic health outcomes. For more information, visit www.alere.com.au



 

Bronze Sponsor

Australian Safety and Quality in Health Care Commission

The Australian Commission on Safety and Quality in Health Care (the Commission) is an Australian Government statutory authority, which is jointly funded by all governments. The Commission's role is to lead and coordinate national improvements in the safety and quality of health care. The Commission works in partnership with patients, consumers, clinicians, managers, policy makers and healthcare organisations to achieve a sustainable, safe and high-quality health system. The Commission works across four priority areas:
  1. Patient safety
  2. Partnering with patients, consumers and communities
  3. Quality, cost and value
  4. Supporting health professionals to provide care that is informed, supported and organised to deliver safe and high-quality health care
 
Key functions of the Commission include developing national safety and quality standards, developing clinical care standards to improve the implementation of evidence-based health care, coordinating work in specific areas to improve outcomes for patients, and providing information, publications and resources about safety and quality.
 
The Commission was funded by the Australian Government Department of Health to establish the Antimicrobial Use and Resistance in Australia (AURA) Surveillance System as a national priority initiative to support the prevention and containment of antimicrobial resistance. The Commission developed AURA by partnering with a number of existing surveillance programs, including the Australian Group on Antimicrobial Resistance, the National Antimicrobial Prescribing Survey (NAPS) and the National Antimicrobial Utilisation Surveillance Program (NAUSP). The Commission also developed two new systems: Australian Passive AMR Surveillance (APAS) using the Queensland Health OrgTRx system and the National Alert System for Critical Antimicrobial Resistances (CARAlert). The states and territories are now also funding the AURA Surveillance System.
 

Bronze Sponsor

Astellas

Bronze Sponsor

Pfizer
 
Working Together for a Healthier World®
 
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world's best-known consumer products.
 
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. 
 
For more than 150 years, Pfizer has worked to make a difference for all who rely on us. 
 

Half Support International Speaker Sponsor

Mayne Pharma
 
Mayne Pharma is a specialty pharmaceutical company focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals, providing patients with access to better and more affordable medicines. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide. 
 
Maybe Pharma has a 30-year track record of innovation and success in developing new oral drug delivery systems and these technologies have been successfully commercialised in numerous products that have been marketed around the world, including Kapanol® (sustained-release morphine used to treat chronic pain), Doryx® (delayed-release doxycycline hyclate used to treat bacterial infections) and Lozanoc® (super bioavailable intraconazole used to treat fungal infections). Furthermore, Mayne Pharma in-licenses novel treatments for Australian patients such as the recently launched Monurol® (fosfomycin trometamol), a single dose antibiotic for uncomplicated cystitis.
 
Mayne Pharma is committed to looking after the health of Australians with more than $110 million invested in R&D over the last 5 years, and we will continue to listen and respond to the needs of local health care professionals. 


Satchel Insert Sponsor

Juno
We are Juno - 
 
A local Australian and New Zealand team, dedicated to supporting you, your hospital and your patients. In partnership with our suppliers, our aim is to lead the category by improving the way products are developed and delivered to market. We want to improve the health of society by providing hospitals and healthcare specialists with the supply of leading off-patent pharmaceuticals. 

Satchel Insert Sponsor

Hologic